National Pension Service Lowers Stake in MetLife, Inc. $MET

National Pension Service cut its holdings in shares of MetLife, Inc. (NYSE:METFree Report) by 35.9% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 947,018 shares of the financial services provider’s stock after selling 529,945 shares during the period. National Pension Service’s holdings in MetLife were worth $76,159,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of MET. Price T Rowe Associates Inc. MD grew its stake in MetLife by 7.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,488,146 shares of the financial services provider’s stock valued at $2,126,734,000 after acquiring an additional 1,824,907 shares during the period. Pzena Investment Management LLC lifted its holdings in MetLife by 6.8% during the second quarter. Pzena Investment Management LLC now owns 9,144,635 shares of the financial services provider’s stock valued at $735,412,000 after purchasing an additional 585,671 shares in the last quarter. Ameriprise Financial Inc. increased its stake in shares of MetLife by 3.6% during the first quarter. Ameriprise Financial Inc. now owns 7,406,512 shares of the financial services provider’s stock worth $594,410,000 after purchasing an additional 259,993 shares in the last quarter. Northern Trust Corp raised its position in shares of MetLife by 0.8% during the 1st quarter. Northern Trust Corp now owns 7,109,423 shares of the financial services provider’s stock worth $570,816,000 after purchasing an additional 57,221 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in MetLife by 3.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 6,671,435 shares of the financial services provider’s stock valued at $535,568,000 after buying an additional 236,698 shares in the last quarter. Hedge funds and other institutional investors own 94.99% of the company’s stock.

MetLife Stock Up 3.1%

Shares of MET opened at $80.17 on Thursday. The stock has a fifty day simple moving average of $79.89 and a two-hundred day simple moving average of $78.90. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.57. The company has a market capitalization of $52.82 billion, a PE ratio of 13.59, a price-to-earnings-growth ratio of 0.70 and a beta of 0.87. MetLife, Inc. has a 52-week low of $65.21 and a 52-week high of $89.05.

MetLife (NYSE:METGet Free Report) last released its quarterly earnings data on Wednesday, November 5th. The financial services provider reported $2.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.30 by $0.07. The firm had revenue of $12.46 billion during the quarter, compared to analysts’ expectations of $18.64 billion. MetLife had a net margin of 5.83% and a return on equity of 19.88%. MetLife’s revenue was down 5.9% compared to the same quarter last year. During the same period last year, the business earned $1.95 earnings per share. As a group, equities analysts forecast that MetLife, Inc. will post 9.65 EPS for the current year.

MetLife Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 9th. Investors of record on Tuesday, November 4th will be issued a $0.5675 dividend. The ex-dividend date is Tuesday, November 4th. This represents a $2.27 dividend on an annualized basis and a yield of 2.8%. MetLife’s dividend payout ratio is currently 42.75%.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the company. Jefferies Financial Group boosted their price objective on MetLife from $100.00 to $103.00 and gave the stock a “buy” rating in a research note on Monday, August 11th. Keefe, Bruyette & Woods reduced their price objective on MetLife from $92.00 to $90.00 and set an “outperform” rating for the company in a research note on Tuesday. Morgan Stanley lifted their target price on shares of MetLife from $94.00 to $97.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 7th. Cowen reaffirmed a “buy” rating on shares of MetLife in a report on Friday, August 22nd. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of MetLife in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, MetLife presently has an average rating of “Moderate Buy” and a consensus price target of $95.00.

Read Our Latest Research Report on MET

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

See Also

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.